Gladstone NOW: The Campaign Join Us on the Journey ✕
76 - 90 of 116 Results Clear All
Qian was awarded the inaugural Boyalife, Science & Science Translational Medicine Award for her research on reprogramming cells in the heart to treat heart failure.
Srivastava Lab Stem Cells/iPSCs
Forward-looking researchers at the Gladstone Institutes are working to solve the stem cell supply problem by pursuing innovative ways to improve stem cell engineering and scale-up tissue manufacturing.
Conklin Lab Ding Lab McDevitt Lab Stem Cells/iPSCs
In a major breakthrough, Gladstone scientists transformed skin cells into heart cells and brain cells using a combination of chemicals and without adding external genes to the cells.
Ding Lab Stem Cells/iPSCs
Gladstone scientists have invented a new way to create micro heart muscle from stem cells using a unique dog bone dish. The three-dimensional tissue is ideal for disease modeling and drug testing.
Conklin Lab Stem Cells/iPSCs
Combining the two most powerful biological tools of the 21st century, scientists at the Gladstone Institutes have manipulated the genome of induced pluripotent stem cells for the first time using a variation of the CRISPR system.
Conklin Lab CRISPR/Gene Editing Stem Cells/iPSCs
Gladstone scientists have discovered how to make a new type of cell that is in between embryonic stem cells and adult heart cells, and that may hold the key to treating heart disease.
Ding Lab Stem Cells/iPSCs
Ten years ago, Shinya Yamanaka revolutionized biological research with his discovery of how to turn ordinary skin cells into stem cells with just four key genes.
Yamanaka Lab Stem Cells/iPSCs
Todd McDevitt has rapidly enchanced how Gladstone thinks about bioengineering and stem cell biology.
McDevitt Lab Stem Cells/iPSCs
Key proteins involved in gene expression depend on each other when forming a heart in an embryo. But, if left alone, they start to run amok.
Stem Cells/iPSCs Congenital Heart Disease
Scientists at the Gladstone Institutes have successfully converted human skin cells into fully-functional pancreatic cells.
Diabetes Ding Lab Stem Cells/iPSCs
With support from the Wilsey Family, Gladstone is studying a rare genetic condition that could provide clues to curing a whole host of diseases.
Philanthropy Stem Cells/iPSCs Rare Diseases
The regenerative medicine program at the Gladstone Institutes has attracted the attention of two global business leaders known for their innovative approach to philanthropy.
Yamanaka Lab Philanthropy Stem Cells/iPSCs
Gladstone has received funding from the National Institutes of Health to continue and expand two exciting projects in cardiovascular research. The funding, totaling more than $6.8 million, supports two teams of scientists and their research on congenital heart disease.
Congenital Heart Disease Bruneau Lab Pollard Lab Srivastava Lab Stem Cells/iPSCs
Gladstone Institutes is pleased to present the inaugural Ogawa-Yamanaka Stem Cell Prize to Masayo Takahashi, MD, PhD.
Awards News Release Ogawa Stem Cell Prize Stem Cells/iPSCs
Using his unique chemical cocktail, Gladstone’s Sheng Ding has regenerated the cells that die in paralyzing spinal cord injuries.
Ding Lab Spinal Cord Injuries Stem Cells/iPSCs
